Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

Shifrut, Eric, Carnevale, Julia, Tobin, Victoria, Roth, Theodore L., Woo, Jonathan M., Bui, Christina T., Li, P. Jonathan, Diolaiti, Morgan E. +2 more·2018·Cell
DOI 10.1016/j.cell.2018.10.024

Cited by (565)

Items 401–500 of 565

  1. Leveraging microRNAs for cellular therapy
    Marko Hasiuk, Marianne Dölz, Romina Marone, Lukas T. Jeker · 2023 · Immunology Letters
  2. CRISPR-based screens uncover determinants of immunotherapy response in Multiple Myeloma
    Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  3. An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human Immune Cells
    Ekaterina V. Vinogradova, Daniel C. Lazar, Radu M. Suciu, Yujia Wang, Giulia Bianco, Yu Yamashita, Vincent M. Crowley, Dave Remillard, Kenneth M. Lum, Gabriel M. Simon et al. · 2019 · SSRN Electronic Journal
  4. A robust platform for BaEVRless-lentiviral synthesis and primary natural killer cell transduction
    Yi-Jun Lan, Quoc Viet Nguyen, Tsu-Lan Chao, Kuo-Lun Yeh, Steven Lin · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Epigenetic control of commensal induced Th2 Responses and Intestinal immunopathology
    Kishan A. Sangani, Morgan E. Parker, Hope D. Anderson, Li Chen, Surya Prakash Pandey, Joseph F. Pierre, Marlies Meisel, Samantha J. Riesenfeld, Reinhard Hinterleitner, Bana Jabrì · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  6. A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells
    Sumana Sharma, Toby Whitehead, Mateusz Kotowski, Emily Zhi Qing Ng, Joseph Clarke, Judith Maria Leitner, Yi‐Ling Chen, Ana Mafalda Santos, Peter Steinberger, Simon J. Davis · 2023 · Life Science Alliance
  7. Boosting immune cells to combat cancer using CRISPR engineering and large-scale in vivo testing
    Michael Hudecek · 2025 · Nature
  8. CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance
    Alex Watterson, Gabriele Picco, Vivien Veninga, Youhani Samarakoon, Chiara Maria Cattaneo, Sara F. Vieira, Emre Karakoç, Shriram G. Bhosle, Thomas Battaglia, Sarah Consonni et al. · 2026 · Cell Reports Medicine
  9. Next-generation CRISPR screens enable causal systems immunology
    Hao Shi, Hongbo Chi · 2026 · The Journal of Experimental Medicine
  10. CRISPR-Cas9 engineering of CAR-T cells: Can non-viral nanoparticles unlock safer and scalable genome editing?
    Bruna My, Andrea Lia, Ludovica Rizzo, Gabriele Maiorano, Antonio Galeone, Ilaria Elena Palamà, Giuseppe Gigli · 2026 · iScience
  11. Redox-metabolic circuits as a central regulator of T cell-based immunotherapy
    Sarah J. McPhedran, Tian Zhao, Julian J. Lum · 2026 · Frontiers in Immunology
  12. Causal intervention validation of gene regulatory signals in scGPT
    Ihor Kendiukhov · 2026 · Journal of Biomedical Informatics
  13. AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition
    Atefeh Bakhshian, Sajjad Ghorghanlu, Fereshteh Fallah Atanaki, Elham Erfani, Azadeh Ashkiyan, Ali Etemadi, Babak Negahdari, Kaveh Kavousi, Gholamali Kardar, Mohammad Ali Mazlomi · 2026 · Journal of Translational Medicine
  14. CBLB Deficiency in Human CD4+ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms
    Jing Song, Warren Anderson, Alex K. Hu, Kazushige Obata‐Ninomiya, Steven F. Ziegler, David J. Rawlings, Jane Hoyt Buckner · 2022 · The Journal of Immunology
  15. GiRAFR improves gRNA detection and annotation in single-cell CRISPR screens
    Qian Yu, Paulien Van Minsel, Eva Galle, Bernard Thienpont · 2023 · Communications Biology
  16. PerturbSeq.db: An Integrated Repository for Comprehensive Analysis of Single-cell Perturbation Data
    Tongxin He, Xiaoxiao Yang, Yang Tong, Xiaochuan Liu, Yihu Wei, Wenhui Wang, Jiapei Yuan, Yuting Wang, Yang Yang · 2025 · Journal of Molecular Biology
  17. Systems Approaches to Unravel T Cell Function and Therapeutic Potential in Autoimmune Disease
    Victor H. Salinas, Olaf Stüve · 2021 · The Journal of Immunology
  18. Genome Editing for Engineering the Next Generation of Advanced Immune Cell Therapies
    Sarah Caroline Gomes de Lima, Daianne Maciely Carvalho Fantacini, Izadora Peter Furtado, Rafaela Rossetti, Roberta Maraninchi Silveira, Dimas Tadeu Covas, Lucas Eduardo Botelho de Souza · 2023 · Advances in experimental medicine and biology
  19. Machine learning reveals genetic modifiers of the immune microenvironment of cancer
    Bridget M. Riley-Gillis, Shirng‐Wern Tsaih, Emily A. King, Sabrina Wollenhaupt, Jonas Reeb, Amy R. Peck, Kelsey K. Wackman, Angela Lemke, Hallgeir Rui, Zoltán Dezső et al. · 2023 · iScience
  20. Pan-Cancer and Single-Cell modelling of genomic alterations through gene expression
    Daniele Mercatelli, Forest Ray, Federico Manuel Giorgi · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Rapid discovery of synthetic DNA sequences to rewrite endogenous T cell circuits
    Theodore L. Roth, P. Jonathan Li, Jasper Friedrich Nies, Ruby Yu, Michelle Ly Thai Nguyen, Youjin Lee, Ryan Apathy, Anna Truong, Joseph B. Hiatt, David Wu et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Cell-based screen identifies human type I interferon-stimulated regulators of Toxoplasma gondii Infection
    Anton G. Gossner, Anna Raper, Musa A. Hassan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Inference of heterogeneous effects in single-cell genetic perturbation screens
    Zichu Fu, Lin Hou · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  24. TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ
    Timothy Chai, Kyle M. Loh, Irving L. Weissman · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Genome editing technology and medical applications
    Liren Wang, Bin Zhou, Dali Li · 2024 · Science China Life Sciences
  26. The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
    Rahul K. Suryawanshi, Priyadarshini Jaishankar, G.J. Correy, Moira M. Rachman, Patrick C. O’Leary, Taha Y. Taha, Yusuke Matsui, Francisco José Zapatero Belinchón, Maria McCavitt-Malvido, Yagmur Umay Doruk et al. · 2025 · eLife
  27. Optimization of Genome-Wide CRISPR Screens Using Dual-Guide RNA Infection with Cas9 Electroporation (DICE)
    Caitlin E. Purman, Charles Lu, Apexa Modi, Vinny Vijaykumar, Michael J. Flister, Anneke I. den Hollander, Sabah Kadri, Joshua D. Stender · 2026 · The CRISPR Journal
  28. Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells
    Devesh Sharma, Roshani Sinha, Benjamin J. Lesch, M. Kyle Cromer · 2025 · STAR Protocols
  29. Rewiring natural killer cells for next-generation cancer therapies
    Aline Pfefferle, Karl‐Johan Malmberg · 2025 · Cancer Cell
  30. The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers
    Marine Potez, Gabriel Roman Souza, Philippe E. Spiess, Shari Pilon‐Thomas, Jad Chahoud · 2025 · Nature Reviews Urology
  31. Large-scale CRISPR-Cas9 screens to define regulators of immune checkpoints
    Michael Mu, Johannes C. Melms, Patricia Ho, Benjamin Izar · 2025 · Methods in cell biology
  32. Mapping the clinical landscape of multifunctional CAR T cells: Targets, trends, and synergies
    Isabella Elias Yonezawa Ogusuku, Nele Knelangen, Boris Engels, Marion S. Subklewe, Dominik Lock · 2026 · Molecular Therapy
  33. Aptamer guided nanomedicines enable precision immune engineering
    Nowar Alsarayreh, Yousef Ijjeh, Hadeel Mohammad Abusaifan, Baidaa AlQuaissi, Nirmeen Elzogheir, Dana A. Alqudah, Sara Al-Mahamid, Somaya Ahmad, Hamdi Nsairat, Alaaldin M. Alkilany et al. · 2026 · Discover Applied Sciences
  34. From CRISPR functional genomics to synthetic interventions: engineering antiviral strategies
    Wenjie Qiao · 2026 · Journal of Virology
  35. Engineering co-emergence in organoid models
    Ivana Vasic, Todd C. McDevitt · 2021 · Progress in Biomedical Engineering
  36. Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors
    Jiayu Li, Shuhan Ma, Hongdi Pei, Jici Jiang, Quan Zou, Zhibin Lv · 2023 · Heliyon
  37. The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer
    Allison Voisin, Maud Plaschka, Marlène Perrin-Niquet, Julie Twardowski, Insaf Boutemine, Baptiste Eluard, Guilhem Lalle, Pierre Stéphan, Khaled Bouherrou, Laurie Tonon et al. · 2024 · Frontiers in Immunology
  38. High‐fidelity CRISPR/Cas12a dual‐crRNA screening reveals novel synergistic interactions in hepatocellular carcinoma
    Qian Chen, Minhui Pang, Peng Chen, Zihao Zhou, Jun Lei, Boxiao He, Zaiqiao Sun, Chonil Paek, Baowei Jing, Yankang Wu et al. · 2024 · Clinical and Translational Medicine
  39. Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome
    Sara Hone Lopez, Stefan Loipfinger, Arkajyoti Bhattacharya, Mathilde Jalving, Sjoukje F. Oosting, T. Jeroen N. Hiltermann, Marco de Bruyn, Elisabeth G.E. de Vries, Jacco Juri de Haan, Rudolf S.N. Fehrmann · 2025 · Cancer Immunology Immunotherapy
  40. Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer
    Yinlong Chen, Qin Chen, Xiaoqing Q. Guo, Qingliang Zheng · 2025 · Journal of Gynecologic Oncology
  41. Targeting HPK1 for cancer immunotherapy: An update on recent medicinal chemistry advances
    Yiyun Song, Zepeng Liao, Xiang Ni, Dexiang Wang, Zhihao Qi, Qi Miao, Sheng Jiang, Kuojun Zhang · 2026 · Bioorganic & Medicinal Chemistry
  42. Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy
    Lingtong Zhi, Yuqing Wang, Z. Zhao, Yabin Guo, Kaiwen Wang, Wenhui He, Changjiang Guo, Zhiyuan Niu, Wuling Zhu, Xuan Zhang · 2026 · Experimental and Molecular Pathology
  43. Reversing T cell dysfunction in a novel in vitro model of T cell exhaustion reveals differential roles of RASA2
    Hilal Saraç, Rachael Nicholson, Rebecca N. Graham, Meera Augustus, R. Taghavi, Dympna J. Connolly, Lindsay Lim, Sofia Da Silva Lourenco · 2026 · Frontiers in Immunology
  44. Insights from pooled CRISPRi single-cell screens in K562 cells reveal gene functions, regulatory networks, and highlight opportunities and limitations
    Hong Zhang, Peifen Zhang, Eric Bindels, Eskeatnaf Mulugeta · 2026 · BMC Genomics
  45. Supercharging the metabolic engine: mitochondrial engineering strategies for CAR-T persistence in solid tumors
    Soohyun Chun, Sanghyeon Yu, Hyun Gu Lee, Man Soo Kim · 2026 · Frontiers in Immunology
  46. Leveraging CRISPR/Cas9 for optimized adoptive T cell therapies: From molecular engineering to clinical manufacturing
    Ji-Hyeon Kim, Hyo Jung Cho, Hyang‐Mi Lee · 2026 · Biochemical and Biophysical Research Communications
  47. Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells
    Brian H. Shim, Q. Henry Zhao, Jack A. Queenan, Blake E. Smith, Michael E. Birnbaum, David R. Liu · 2026 · Cell Reports
  48. An InDel genomic variant within a bifunctional super-enhancer for LINC00636 and CD47 regulation in breast cancer
    Carolina Di Benedetto, Amelia Tsark, Daniza Diane Acenas, Alysia Thach, Anmol Singhal, Valentina Opazo-Mellado, Anthony Rodriguez-Lemus, Mustapha El Zeini, Hui Zhang, Catherine Park et al. · 2026 · Cellular and Molecular Life Sciences
  49. Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma
    Chunrong Yang, Yujie Li, Yuchen Yang, Qiankun Ni, Zeyu Zhang, Yi Chai, Jinghong Li · 2023 · Angewandte Chemie
  50. A convenient viral transduction based method for advanced multi-engineering of primary human (CAR) T-cells
    Jort J. van der Schans, Afroditi Katsarou, George Kladis, Citlali Bar, Max Medina-Ramírez, Maria Themeli, Tuna Mutis · 2024 · Journal of Genetic Engineering and Biotechnology
  51. Computational modeling of metabolism in oncology
    Linda E. Fong, Meng Jin, Samir Kharbanda, Marc Creixell, Xiumin Wu, David Zhang, Juan Dubrot, Kathleen B. Yates, Robert T. Manguso, Benjamin Kaufmann-Malaga et al. · 2025 · Elsevier eBooks
  52. Single-Cell RNA Sequencing (sc-RNAseq) in the Development of Biomedical Therapeutics
    Phei Er Saw, Erwei Song · 2025 · Springer eBooks
  53. Genome-wide CRISPRa screens identify modulators of CAR T survival across diverse tumor cytokine milieus
    Benjamin C. Curtis, Cailyn H. Spurrell, Lindsay Flint, Aalton M Lande, Marissa Leonardi, James M. Rosser, Tavie Parker, Tiffanie Chai, Ardizon Valdez, Ryma Toumi et al. · 2026 · Molecular Therapy — Nucleic Acids
  54. Screening for the Next-Generation T Cell Therapies
    Jun Guo, Chenqi Xu · 2020 · Cancer Cell
  55. Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do
    Tao Yin · 2021 · Precision Clinical Medicine
  56. Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategies
    Gianna T Flint, Patricia R Drake, Joel P Goetz, Marwah M Albaker, Julian N. Rosenberg · 2021 · Current Opinion in Biotechnology
  57. Mitochondria-associated gene expression perturbation predicts clinical outcomes and shows potential for targeted therapy in neuroblastoma
    Chengwei Chai, Yan Chen, Yuanyuan Luo, Hong Zhang, Zhihua Ye, Xiaobing He, Yan Zou, Yingyi Xu, Le Li, Jue Tang et al. · 2023 · Frontiers in Pediatrics
  58. Genetic Manipulation/Modulation for Target Discovery and Validation
    Christophe Lanneau, Georges Kalouche, Xinming Cai, François Lo-Presti, Christoph Potting · 2019 · Methods and principles in medicinal chemistry
  59. Spatiotemporal Control of Genomics and Epigenomics by Ultrasound
    Yiqian Wu, Ziliang Huang, Yahan Liu, Chi Woo Yoon, Kun Sun, Yinglin Situ, Phuong Ho, Yuan Zhou, Linshan Zhu, Justin Eyquem et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Dynamic chromatin architecture identifies new autoimmune-associated enhancers for IL2 and novel genes regulating CD4+ T cell activation
    Matthew C. Pahl, Prabhat Kumar Sharma, Rajan M. Thomas, Zachary Thompson, Zachary Mount, James A. Pippin, Peter A. Morawski, Peng Sun, Chun Su, Daniel Campbell et al. · 2024 · eLife
  61. High-throughput single-cell CRISPRi screens stratify neurodevelopmental functions of schizophrenia-associated genes
    Umut Yildiz, Annique Claringbould, Mikael Marttinen, Víctor Campos-Fornés, Mantha Lamprousi, Manu Saraswat, Mathias Saver, Daria Bunina, Michael W. Dorrity, Judith B. Zaugg et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  62. Base-editing a single missense mutation in A20 enhances CAR-T cell efficacy
    Adam Blaisdell, Stefanie Bachl, Luis R Sandoval, Carter Ching, Christopher Bowman, Nupura Kale, Manu Prabandham, Morgan E. Diolaiti, Claire C. Havig, Rommel Advincula et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Cysteine reactivity profiling links metabolic rewiring to the dysfunctional human T cell proteome
    Hiroyuki Kojima, Charlotte R. Wayne, Luis F. Somarribas Patterson, Henry Sanford, Tzu-Jou Chen, Ya-Hui Lin, Joshua David Schoenfeld, Lisa H.F. McGary, Yanting Chen, Korbinian Nepomuk Kropp et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Multi-enhancer regulatory hubs control Th17 cell identity
    Keith Siklenka, Chuangchuang Zhang, Liqing Li, Morgan E. Parker, Naren U. Mehta, Alejandro Barrera, Revathy Venukuttan, Gregory E. Crawford, Charles A. Gersbach, Maria Ciofani et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  65. In vivo CRISPR-based screen identifies ZC3H12C as a mediator of CAR-T cell dysfunction in solid tumors
    Paula Barbao, Alba Rodríguez-García, Ariel Galindo‐Albarrán, Marta Giménez-Alejandre, Pablo Clavero, Teresa Lobo‐Jarne, Marta Botas, Guillem Colell, Joan Castellsagué, Guim Cascalló et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  66. PerturbPlan: An analytical framework for designing Perturb-seq experiments
    Ziang Niu, Yihui He, James Galante, Andreas R. Gschwind, Judhajeet Ray, Lars Michael Steinmetz, J Engreitz, Eugene Katsevich · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Towards best-practice approaches for CRISPR/Cas9 gene engineering
    Claude Van Campenhout, Pauline Cabochette, Anne-Clémence Veillard, Miklós Laczik, Agnieszka Zelisko-Schmidt, Céline Sabatel, Maxime Dhainaut, Benoît Vanhollebeke, Cyril Gueydan, Véronique Kruys · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy
    Rigel J. Kishton, Shashank J. Patel, Suman Kumar Vodnala, Amy E. Decker, Yogin K. Patel, Madhusudhanan Sukumar, Tori N. Yamamoto, Zhiya Yu, Michelle Ji, Amanda N. Henning et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Laparoscopic fundoplication in infants with life-threatening gastroesophageal reflux disease and associated anomalies as a predictor for surgical intervention
    R Sridhar, Jegadeesh Sundaram, Selvapriya Bharathi, Prakash Agarwal, Madhu Ramasundaram · 2020 · Indian Journal of Child Health
  70. CRISPR/Cas-based Functional Genomic Approaches to Phenotypic Screening
    Beverley J. Isherwood, Samantha E. Peel, Shanade Dunn, Ultan McDermott · 2020 · Royal Society of Chemistry eBooks
  71. Erasing iatrogenic neoantigens from in vivo CRISPR screens
    Fei Yi, Christopher Austin Klebanoff · 2021 · Immunity
  72. Programming Novel Cancer Therapeutics: Design Principles for Chimeric Antigen Receptors
    Andrew J. Hou, Yvonne Y. Chen · 2021 · Wiley eBooks
  73. 24th “Nantes Actualités en Transplantation” and 4th “LabEx Immunotherapy-Graft-Oncology” NAT and IGO Joint Meeting “New Horizons in Immunotherapy”
    Noémie Joalland, Kathleen Ducoin, Gwenann Cadiou, Catherine Rabu, Carole Guillonneau · 2021 · Frontiers in Immunology
  74. Brisbane River Expressways as Landscape Urbanism
    Glenn S. Thomas · 2001
  75. 〔504〕金属の摩耗に及ぼす温度の影響, 〔J.K.Lancaster, Phys.Soc., Proc., Sections B., 1957-1,Vol.20,Part 1,p.112〜118,図5〕
    笹田直 · 1958 · Nihon Kikai Gakkaishi/Journal of the Japan Society of Mechanical Engineers
  76. Advances and application of CRISPR-Cas systems
    Rongming Liu, Liya Liang, Margaret Habib, Emily F. Freed, Carrie A. Eckert · 2022 · Elsevier eBooks
  77. Genome Editing Applications in Cancer T Cell Therapy
    William A. Nyberg, Justin Eyquem · 2022 · Wiley eBooks
  78. Commercially Available Reagents and Contract Research Services for CRISPR‐Based Studies
    Klio Maratou, Aaron T. Cheng, Fiona M. Behan, Ning Sun, Quinn Lu · 2022 · Wiley eBooks
  79. Functional Genomics
    Davide Gianni, Leire Escudero‐Ibarz · 2022 · Wiley eBooks
  80. Mapping the regulators of key immune genes and disease networks
    2022 · Nature Genetics
  81. Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease
    Frontiers Production Office · 2023 · Frontiers in Immunology
  82. Mastering the game of hide and seek
    Annelisa M. Cornel · 2023
  83. Supplementary Data from Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2
    Patrick C. O’Leary, Huadong Chen, Yagmur Umay Doruk, Tess Williamson, Benjamin J. Polacco, Andrew S. McNeal, Tanushree Shenoy, Nupura Kale, Julia C. Carnevale, Erica J. Stevenson et al. · 2023
  84. Chromatin conformation dynamics during CD4+ T cell activation implicates autoimmune disease-associated genes and regulatory elements
    Andrew D. Wells, Matthew C. Pahl, Prabhat Kumar Sharma, Rajan M. Thomas, Zachary Thompson, Zachary Mount, James A. Pippin, Peter A. Morawski, Daniel Campbell, Struan F.A. Grant et al. · 2023 · Research Square
  85. Decoding T cell state-specific regulomes in cancer
    Giulia Escobar, Ana Carrizosa Anderson · 2024 · Cell Research
  86. Towards inmunotherapeutic exploitation strategies of rotumor and antitumor cytokines
    Irene Olivera · 2023
  87. Additional file 3 of PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
    Zheng Li, Yaming Li, Xiaolong Wang, Qifeng Yang · 2021 · Figshare
  88. Additional file 7 of PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
    Zheng Li, Yaming Li, Xiaolong Wang, Qifeng Yang · 2021 · Figshare
  89. Additional file 2 of PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
    Zheng Li, Yaming Li, Xiaolong Wang, Qifeng Yang · 2021 · Figshare
  90. Additional file 1 of PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
    Zheng Li, Yaming Li, Xiaolong Wang, Qifeng Yang · 2021 · Figshare
  91. Additional file 9 of PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
    Zheng Li, Yaming Li, Xiaolong Wang, Qifeng Yang · 2021 · Figshare
  92. Design and characterization of multiplex gene-edited CAR-T cells resistant to orthogonal immunosuppressive pathways within the solid tumor microenvironment
    Ryan C. Murray · 2024
  93. Reviewer #3 (Public Review): Dynamic chromatin architecture identifies new autoimmune-associated enhancers for IL2 and novel genes regulating CD4+ T cell activation
    2024 · eLife
  94. Reviewer #2 (Public Review): Dynamic chromatin architecture identifies new autoimmune-associated enhancers for IL2 and novel genes regulating CD4+ T cell activation
    2024 · eLife
  95. CRISPR screening meets spatial omics: Opportunities and challenges
    Yinxing Ma · 2024 · Elsevier eBooks
  96. Peptide-Assisted CRISPR/Cas9 Delivery to Tumors
    Oskar Gustafsson, Samir EL Andaloussi, Joel Z. Nordin · 2025 · Methods in pharmacology and toxicology
  97. Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
    Carli M. Stewart, Claudia Manriquez Roman, Saad S. Kenderian · 2025 · Journal of Visualized Experiments
  98. A review on single-cell perturbation data analysis
    Zichu Fu, Ming Yang, Lin Hou · 2025 · Scientia Sinica Mathematica
  99. Strategies to enhance anti-leukaemia immunotherapy
    Memnon Lysandrou, Robert Zeiser · 2025 · Current Opinion in Pharmacology
  100. Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
    Yu Yuan, Ziyu Jiang, Yuxin Zeng, Jiawen Tang, Jiang Luo, Conghua Xie, Yan Gong · 2025 · Journal of Visualized Experiments